Cao et al. showed that β-arrestin 2 can hinder the activation of NF-κB by inhibiting the phosphorylation of IkBα, thus reducing the proliferation and migration of renal cell carcinoma in vitro. The gene discussed is NFKB1; the disease is renal cell carcinoma.